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I. INTRODUCTION
Imagine for a moment that after borrowing a credit card, a teenager strolls down
the block to the local pharmacy. At the pharmacy, a doctor is at the door waiting and
willing to prescribe anything to anyone. After answering a few questions, the
teenager receives his prescription, where he takes it to the drug counter and places an
order for a dangerous amount of painkillers. Imagine further that the teenager
develops an addiction to the drugs and purchases an increased dosage each visit until
finally, the teen dies from an overdose from the easily obtained prescription drugs.
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The situation described above is drawn from a real event.1 Nearly the very same
chain of events happened to seventeen year old Ryan Haight. The only difference
was that Ryan never even had to leave his home. Ryan visited an online pharmacy
and obtained a prescription from a doctor he had never met for drugs he did not need.
Using his father’s credit card, Ryan had the drugs delivered to his home.2 Tragically,
Ryan became addicted to the drugs and eventually died of an overdose at age
eighteen.3
Ryan’s tragic story was preventable. There are ample barriers and regulations in
place that would have prevented Ryan’s death if he had tried to obtain the drugs at
his local pharmacy rather than one he found online.4 The need for the government to
regulate online pharmacies is well documented,5 yet the federal government has
largely avoided any meaningful regulation until passing the Ryan Haight Online
Pharmacy Consumer Protection Act in October of 2008.6
The transition from brick and mortar storefronts into cyberspace has presented
both opportunities and challenges. This is especially true for online pharmacies,
where medicine and technology come together in a relatively new way. Online
pharmacies present a unique challenge by creating a tension between providing
inexpensive remote heath care and the safety of in person health care.
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is the first
federal bill passed specifically to regulate online pharmacies. In this note, I will
identify the strengths and weaknesses of the Ryan Haight Online Pharmacy
Consumer Protection Act of 2008 (the “Ryan Haight Act” or the “Act”) and make
suggestions for future online pharmacy legislation.
Part II of this note provides background information about online pharmacies.
Part III discusses the agencies responsible for online pharmacy regulation and
explains existing federal regulation. In explaining the existing online pharmacy
regulation, Part III of this note also identifies the strengths and weaknesses of the
federal regulation. Part IV provides suggestions for future online pharmacy
legislation. Part V of the note is a short explanation of how online pharmacies will
be successfully regulated through federal registration. This note concludes that the
1
Ryan’s Cause, http://www.ryanscause.org (last visited April 15, 2010.). Ryan began
using the drugs when he was seventeen years old. Ryan’s parents, both of whom worked in
the medical field, were shocked to discover that the highly regulated drugs they work with
every day were so easily obtained. Since 2001, Ryan’s friends and family have worked to
further the cause of online pharmacy regulation. Id.
2

Id.

3

Id.

4

United States v. Fuchs, 467 F.3d 889, 899 (5th Cir. 2006) (“Section 841(a)(1) makes it
‘unlawful for any person knowingly or intentionally. . . to manufacture, distribute, or dispense
. . . a controlled substance.’” (quoting United States v. Moore, 423 U.S. 122, 124 (1975))).
5
See generally Phil Ayers, Prescribing a Cure for Online Pharmacies, 72 TENN. L. REV.
949 (2005); Ludmila Bussiki Silva Clifton, Internet Drug Sales: Is It Time To Welcome “Big
Brother” Into Your Medicine Cabinet?, 20 J. CONTEMP. HEALTH L. & POL’Y 541 (2004);
Kristin Yoo, Self-Prescribing Medication: Regulating Prescription Drug Sales on the Internet,
20 J. MARSHALL J. COMPUTER & INFO. L. 57 (2001).
6

110 P.L. 425 (Oct. 15, 2008).
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current federal regulation of online pharmacies provides much needed progress but
must be improved to ensure adequate protection.
II. TYPES OF ONLINE PHARMACIES
Generally speaking, “[o]nline pharmacies are divided into three broad categories:
traditional online pharmacy, prescribing-based site pharmacy, and rogue pharmacy.”7
The traditional pharmacies are little more than an online extension of brick and
mortar pharmacies.8 Often, this type of pharmacy is a nationally known or
recognized chain. Traditional online pharmacies require a prescription before an
order for medicine will be filled or delivered.9
Traditional online pharmacies place value on consumer protection and have selfimposed standards that are commonly more protective than the regulations the Ryan
Haight Act will put in place. CVS and Walgreens provide two well-known examples
of traditional pharmacies. Traditional online pharmacies place value on consumer
protection and have self-imposed standards that are more commonly more protective
than the regulation that what the Ryan Haight Act will put in place. The National
Association of Boards of Pharmacy, a non-government association that rates online
pharmacies, developed the Verified Internet Pharmacy Practice Sites (VIPPS).10 The
VIPPS program was developed “[i]n response to public concern of the safety of
pharmacy practices on the Internet.”11 Eligible online pharmacies display a seal
prominently on the front page of their site after VIPPS accreditation.12 To earn
VIPPS accreditation, a pharmacy must “comply with the licensing and inspection
requirements of their state and each state to which they dispense pharmaceuticals.”13
Furthermore, the pharmacies must demonstrate compliance with “VIPPS criteria
including patient rights to privacy, authentication and security of prescription orders,
adherence to a recognized quality assurance policy, and provision of meaningful
consultation between patients and pharmacists.”14 Many of the VIPPS requirements
go above and beyond the Ryan Haight Act’s requirements for online pharmacies.

7

20 J. Contemp. Health L. & Pol'y 541 at 546.

8

Id.

9

Id.

10

Verified Internet Pharmacy Practice Sites (VIPPS) – The National Association of
Boards of Pharmacy, http://vipps.nabp.net/verify.asp (last visited Feb. 12, 2009). The VIPPS
program was created by the National Association of Boards of Pharmacy (NABP). The
NABP was established over 100 years ago to “assist state licensing boards in developing,
implementing, and enforcing uniform standards to protect the Public Health.” The NABP has
member boards from every state. Canada and Australia are also represented in the association.
Internet consumers may check online pharmacies for VIPPS accreditation by simply entering
the website URL in a site-checker. Id.
11

Id.

12

Id.

13

Id.

14

Id.
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A second category of online pharmacy, prescribing-based, is a remote
consultation pharmacy.15 This type of pharmacy will often provide both the
prescription and the medication.16 A customer obtains a prescription after filling out
a short questionnaire that is subsequently reviewed by a doctor for approval.17
Because the doctors are often affiliated with the pharmacy site, most of the
prescriptions are approved.18 Remote consultation pharmacies will be most affected
by the Ryan Haight Act.19
To some, remote consultation pharmacies are a legal gray area.20 Under good
faith operation, these pharmacies potentially offer consumers the most convenience,
privacy, and savings.21 A well-informed consumer would be able to address all of
his or her pharmacy needs through one stop shopping. The problems associated with
remote consultation pharmacies are potentially deadly when any of the parties
involved act with malicious, negligent or improper motives. For example, the
consumer may be self-diagnosing a serious medical problem incorrectly or may fill
out the online questionnaire dishonestly. Or perhaps the doctor, who is often paid
for each prescription dispensed, over-prescribes the patients so that he or she may
make more money. Worse yet, the entire website may be a sham pharmacy designed
simply to sell pills to addicts. The Ryan Haight Act will address many of these

15
Ancier v. Dep't of Health, Med. Quality Assurance Comm'n, 140 Wn. App. 564, 568
(Wash. Ct. App. 2007). “Applicants must attest they have undergone recent physical
examinations, will schedule routine physicals for the duration of the prescription, and will
consult local physicians or pharmacists about any adverse reactions or complications.” Id.
16
Trust-Meds.com, http://www.trust-meds.com/faq.php#q12, (last visited Feb. 16, 2009);
Best E-Pharm.com, http://www.bestepharm.com/faq.php?cat=faq#200 (last visited Feb. 16,
2009). The above websites are examples of remote consultation pharmacies that were
operational at the time of submission.
17

See Ancier, supra note 15. Consumers obtained prescriptions by filling out a relatively
simple questionnaire. The questionnaire is then reviewed by a doctor. In Ancier, the doctor
reviewed some 200,000 requests and issued 180,000 prescriptions in a three year period. The
doctor did not physically examine any of the consumers receiving prescriptions. Some
consumers described their medical conditions as “Need [medication].” Id.
18
Id. “Between 2001 and 2004, [the doctor] reviewed approximately 200,000 requests and
issued 180,000 prescriptions. [The doctor] did not physically examine or personally interview
any of the persons receiving the prescriptions.” Id.
19

See generally Ryan Haight Online Pharmacy Consumer Protection Act of 2008, 110
P.L. 425 (Oct. 15, 2008).
20
Donald Cooley, InternetDrugLaw.com, http://internetdruglaw.com/topics/ryan-haightact/ (Last visited Feb. 12, 2009). (Donald R. Cooley is a criminal defense attorney who posts
recent developments concerning internet drug laws on his blog. In many of his posts, Cooley
argues that online pharmacies were legal before the Ryan Haight Act was signed into
legislation.).
21

PharmacyChecker.com: About Online Pharmacies, http://www.pharmacychecker.com/
aboutop.asp (last visited Mar. 24 2009). The benefits of remote consultation pharmacies
include lower prices, privacy, greater access to generic products, convenience, and medical
information. Id.
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concerns in an attempt to clarify the government’s stance on the legality of remote
consultation pharmacies.22
A third online pharmacy category is the “rogue pharmacy.”23 The defining
characteristic of a rogue pharmacy is that medication is dispensed without a
prescription.24 Rogue pharmacies are considered extremely dangerous and are
currently illegal.25 Many of them operate from outside of the United States.26 Rogue
pharmacy customers are often the targets of fraud and counterfeit medicine.27 There
is little difference between this type of pharmacy and back alley drug dealers.28
Although rogue pharmacies are a threat to the safety of internet pharmacy
consumers, the government’s stance on them is clear. When the government
becomes aware of rogue pharmacies, they are shut down and the operators are
prosecuted.29 The Ryan Haight Act may have some effect on rogue pharmacies,
particularly through the amendment that will increase the length of prison sentences
for convicted parties.30 However, the Ryan Haight Act will not substantively change
the way consumer, the government, and rogue online pharmacies interact.31
22

Government Technology, http://www.govtech.com/gt/419355 (last visited Mar. 24,
2009). “Rather than try to block all online pharmaceutical sales, the Ryan Haight Act will put
online pharmaceutical sales on an equal regulatory footing with those sales through a brickand-mortar facility.” Id.
23

Ayres, supra note 5, at 954.

24

5 Star Pharma, http://www.fivestarpharma.com/ (last visited Feb. 16, 2009). 5 Star
Pharma is an example of a rogue pharmacy website that was operational at the time of article
submission. The website is based outside of the United States and purports to mail controlled
substances without a prescription. Id.
25

Online rogue pharmacies still booming, MSNBC.Com, http://www.msnbc.msn.com/id/
20409515/ (last visited Mar. 24, 2009). Rogue pharmacies often approach retired or in debt
doctors and offer them an opportunity to review prescription questionnaires. Doctors are
generally paid about 20 dollars for each prescription. The prescriptions are then sent to
pharmacies willing to fill them. Id.
26

Dispensing and Purchasing Controlled Substances over the Internet, 66 Fed. Reg. 82,
21181, 82 21184 (Apr. 27, 2001) (notice as to application of current laws related to
dispensing, purchasing, or importing controlled substances). Rogue online pharmacies are
particularly dangerous because they often intentionally mislead consumers. The DEA warns
that “[t]hese sites often advise that there have been changes to the U.S. law that authorize the
customer to import a controlled substance into the United States without benefit of a
prescription.” Dispensing and Purchasing Controlled Substances over the Internet.
27

Food and Drug Administration, Counterfeit Drugs Questions and Answers,
http://www.fda.gov/oc/initiatives/counterfeit/qa.html (last visited Dec. 2, 2008). The Food
and Drug Administration (FDA) credits the strong regulatory framework of the United States
for low occurrence of counterfeit medicine. Consumers who purchase drugs from foreign
entities are therefore more likely to receive counterfeit drugs. A counterfeit drug is a drug
sold under an improper name. Counterfeit drugs may contain dangerous incorrect ingredients
that may have deadly side effects. Id.
28

See Dispensing and Purchasing Controlled Substances over the Internet, supra note 26.

29

Id.

30

See 21 U.S.C. § 841 et seq. “[I]n the case of any controlled substance in schedule III,
such person shall be sentenced to a term of imprisonment of not more than 10 years and if
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III. EXISTING LEGISLATION
A. About the Regulatory Agencies
Online pharmacies face federal regulation primarily from the United States Food
and Drug Administration (FDA) and the United States Drug Enforcement
Administration (DEA).32 Currently, the FDA regulates online pharmacies through
the Federal Food, Drug, and Cosmetic Act (FD&C).33 The DEA regulates online
pharmacies through the Controlled Substances Act of 1974.34 The agencies regulate
different aspects of online pharmacies. The FDA tends to regulate non-controlled
substances while the DEA regulates controlled substances. The two agencies often
work together; for example, the “FDA assists DEA in deciding how stringent DEA
controls should be on drugs that are medically accepted but that have a strong
potential for abuse.”35
According to its mission statement, the FDA is “is responsible for protecting the
public health by assuring the safety, efficacy, and security of human and veterinary
drugs, biological products, medical devices, our nation’s food supply, cosmetics, and
products that emit radiation.”36 The FDA officially came into existence after the
death or serious bodily injury results from the use of such substance shall be sentenced to a
term of imprisonment of not more than 15 years” Id.
31
See generally Dispensing and Purchasing Controlled Substances over the Internet, supra
note 26. In the eyes of the federal government and the DEA, rogue pharmacies have always
been considered illegal and a danger to consumer health. Id.
32
What FDA Doesn’t Regulate, http://www.fda.gov/AboutFDA/WhatWeDo/WhatFDA
DoesntRegulate/default.htm (last visited Apr. 12, 2010). The DEA also “establishes limits on
the amount of [prescription drugs that have a strong potential for abuse] that are permitted to
be manufactured each year.” Id.
33
See Federal Food, Drug and Cosmetic Act, 21 U.S.C. 331 (2007). Relevant to online
pharmacy regulation, the FD&C prohibits “[t]he introduction or delivery for introduction into
interstate commerce of any food, drug, device, or cosmetic that is adulterated or misbranded.”
Id. It also prohibits “[t]he doing of any act which causes a drug to be a counterfeit drug, or the
sale or dispensing, or the holding for sale or dispensing, of a counterfeit drug.” Id.
34

21 U.S.C. § 801 et. seq.

35

Linda Bren, Agencies Team Up in War Against Internet Health Fraud, http://www.fda.
gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm137264.htm. The
Federal Trade Commission (FTC) has played a somewhat smaller role in regulating online
pharmacies. In 2001, the FTC created “Operation Cure.All” to crack down on companies
making fraudulent health product claims. Operation Cure.All resulted in numerous product
seizures and recalls, arrests, and convictions. Id.
36

FDA’s Mission Statement, http://www.fda.gov/opacom/morechoices/mission.html (last
visited Feb. 12, 2009). A portion of the FDA’s Mission Statement reads :
The FDA is responsible for protecting the public health by assuring the safety,
efficacy, and security of human and veterinary drugs, biological products, medical
devices, our nation’s food supply, cosmetics, and products that emit radiation. The
FDA is also responsible for advancing the public health by helping to speed
innovations that make medicines and foods more effective, safer, and more affordable;
and helping the public get the accurate, science-based information they need to use
medicines and foods to improve their health.
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Wiley Act was passed in 1906.37 The Wiley Act placed the Bureau of Chemistry in
charge of label regulation.38 At its inception, and until 1912, the FDA was primarily
focused on regulating food, rather than drug products.39
The FD&C was first passed in 1938 after a series of tragic and needless deaths.40
The FD&C “brought cosmetics and medical devices under control, and it required
that drugs be labeled with adequate directions for safe use . . . and mandated premarket approval of all new drugs.”41 This meant that drugs needed FDA approval
before manufactures or anyone else could sell them.42 The FDA regularly uses these
provisions as its foundation in online pharmacy regulation.43 A common scenario
where the duty to regulate an online pharmacy falls on the FDA usually involves a
website purporting to sell cures for cancer, AIDS, etc.
The FDA has dedicated extensive effort toward educating the public concerning
the risks and benefits of purchasing medicine from an online pharmacy.44 Aware of
the rapid increase in online pharmacy sales,45 the FDA’s praise of online pharmacies
37
John P. Swann, FDA History—Part I: The 1906 Food and Drugs Act and Its
Enforcement,
http://www.fda.gov/AboutFDA/WhatWeDo/History/Origin/ucm054819.htm
(last visited Oct. 31, 2009). After 1912, the Bureau of Chemistry focused its efforts on “patent
medicines” in an increased effort to regulate drugs. Although frustrated by regulatory laws,
“seizures of misbranded and adulterated drugs nevertheless increased in the 1920s and 1930s.”
Id.; What FDA Regulates, http://www.fda.gov/comments/regs.html (last visited Feb. 12,
2009). Currently, the FDA regulates a wide array of products. Categorically, the FDA
regulates biologics, cosmetics, drugs, foods, medical devices, radiation-emitting electronic
products, and veterinary products. Id.
38

Id.

39

Id.

40

Id.

41

Id.

42

Id.

43

Id.

44

Buying Prescription Medicine Online: A Consumer Safety Guide,
http://www.fda.gov/Drugs/ResourcesForYou/ucm080588.htm (last visited Oct. 31, 2009).
One example of the effort to educate internet consumers, offers a practical guide that explains
the basic risks and recommendations when dealing with an online pharmacy. Id. The guide
breaks down the different risks of the websites versus the risks of the medicine. Id. Website
risks include dealing with an unlicensed body a potential lack of privacy. Id. Medicine risks,
however, pose serious health risks. Id. The FDA also advises consumers to meet and talk to
their doctor. Id. Finally, the guide provides links to reputable websites designed to help
consumers find legitimate online pharmacies, as well as links to additional online pharmacy
consumer education information. Id.
45

William K. Hubbard gave testimony before the United States House of Representatives
in an effort to bring the major issues associated with the growing online pharmacy industry to
light. Hubbard explained that “[w]ith greater and greater frequency, consumers are using the
Internet to access health related information and products. Sales of consumer products over the
Internet have grown rapidly, including the sale of drugs.” Internet Prescription Drugs:
Hearing Before the H. Comm. On Government Reform 108th Cong. (2004) (statement of
William K. Hubbard, Associate Comm’r for Policy and Planning, Food and Drug
Administration).
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exclaim that pharmacies have provided “significant benefits to consumers.”46
William K. Hubbard, of the FDA, testified before the United States House of
Representatives that “[m]any managed health care organizations are … turning to
online prescription plans as a means of providing quality service at a lower cost.”47
The advantages offered by online pharmacies include convenient and open access to
drugs for disabled or homebound consumers, wider selection, lower prices, 24-hour
shopping, and privacy.48 Additionally, technological aspects such as e-mail
reminders, hyperlinks, and access to drug information can be substantial advantages
over brick and mortar pharmacies.49
The FDA devotes comparatively little effort praising online pharmacies in
relation to the effort spent warning consumers concerning the risks of purchasing
medicine through an online pharmacy. Much of the FDA’s concern relates to the
practices of remote consultation and rogue pharmacies. The FDA describes these
pharmacies as “a serious potential threat to the health and safety of American
citizens.”50 The list of FDA risk concerns from internet pharmacies includes
dangerous side effects from incorrect prescriptions, dangerous drug interactions,
drug contamination, outdated and counterfeit drugs.51

46

Id.

47

Hubbard’s statement in full reads: “The growth in online drug sales by reputable
pharmacies has provided significant benefits to consumers. Many managed health care
organizations are searching for ways to achieve cost savings and are turning to online
prescription plans as a means of providing quality service at a lower cost.” Id.
48

Id.

49

Expanding on the benefits of online pharmacies, Hubbard explained that the internet
offers advantages in the amount of information available and the ease of obtaining it, for
example “detailed information on drug interactions . . . e-mail [notification] if the drug they
ordered has been recalled [or] a cheaper generic version of the drug becomes available . . .
[h]yperlinks and search programs [that] provide online customers with written product
information and references to other sources of health information more easily than in the
traditional storefront.” Id.
50
Nearly five years before the Ryan Haight Act becomes effective, Hubbard’s testimony
makes clear that federal regulatory agencies, such as the FDA, were aware of the need to
regulate online pharmacies well before the Ryan Haight Act was passed. Id. Hubbard cites
the American Medical Association and the Federation of State Medical Boards as other
regulatory agencies advocating for online pharmacy regulation. Id. Hubbard specifically
describes the dangers of using remote consultation pharmacies as “practicing what amounts to
self-diagnosis” and a means to bypass regulation. Id. Before the Ryan Haight Act, the only
piece of internet pharmacy targeted legislation, the FDA was limited to advocating voluntary
regulatory regimes, such as VIPPS. Id. Any FD&C Act violations perpetuated by online
entities were handled as if it “were . . . another sales medium, such as a storefront or a
magazine.” Id. The testimony offered before the U.S. House of Representatives should have
been a wakeup call to legislators about the dangers of access to unregulated medicine and
controlled substances. Id.
51

Id.
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The duty to regulate controlled substances was initially that of the FDA through
the Drug Abuse Control Amendment of 1965.52 The Drug Abuse Control
Amendment gave the FDA “control over amphetamines, barbiturates, hallucinogens,
and other drugs of considerable abuse potential.”53 However, the duty to regulate
controlled substances was eventually delegated to the DEA.54 President Nixon
created the DEA through an executive order in 1973.55 The DEA regulates “[i]llegal
drugs with no approved medical use--such as heroin and marijuana.”56 The mission
statement of the DEA requires the DEA to “enforce the controlled substances laws
and regulations of the United States.”57
Both the DEA and FDA have published guides to educate consumers about the
risk and benefits of online pharmacies.58 These guides offer tips on safety, the law,
and what to look for in a reputable online pharmacy.59 For example, the FDA
52

John P. Swann, FDA History—Part III: Drugs and Foods Under the 1938 Act and Its
Amendments,
http://www.fda.gov/AboutFDA/WhatWeDo/History/Origin/ucm.055118.htm
(last visited Oct. 31, 2009).
53

Id.

54

Id.

55

Id.

56

United States Food and Drug Administration, What FDA Does Not Regulate,
http://www.fda.gov/comments/noregs.html (last visited Feb. 12, 2009).
57
U.S. Drug Enforcement Administration, DEA Mission statement, http://www.usdoj.gov/
dea/agency/mission.htm (last visited Feb. 12, 2009). The mission statement of the DEA reads:

The mission of the Drug Enforcement Administration (DEA) is to enforce the
controlled substances laws and regulations of the United States and bring to the
criminal and civil justice system of the United States, or any other competent
jurisdiction, those organizations and principal members of organizations, involved in
the growing, manufacture, or distribution of controlled substances appearing in or
destined for illicit traffic in the United States; and to recommend and support nonenforcement programs aimed at reducing the availability of illicit controlled
substances on the domestic and international markets.
58
The United States Food and Drug Administration, The Possible Dangers of Buying
Medicines Over the Internet, http://www.fda.gov/ForConsumers/ConsumerUpdates/
ucm048396.htm (last visited Apr. 15, 2010). In yet another effort to inform consumers, the
FDA provides easy to read material that explains how consumers can identify whether or not
an online pharmacy or its products are legitimate. Id.; Drug Enforcement Administration,
Office of Division Control, Questions and Answers: Dispensing and Purchasing Controlled
Substances Over the Internet, http://web.archive.org/web/20080722205257/http://www.dea
diversion.usdoj.gov/faq/internetpurch.htm (last visited Apr. 15, 2010).
The DEA also
provides consumer friendly and easy to read materials regarding online pharmacies. However,
the material from the DEA tends to focus on the criminal aspects concerning rogue
pharmacies, whereas the FDA focused on potential health risks. The DEA correctly identifies
one of the major issues for rogue sites – many consumers are unaware that they are breaking
the law. The educational material is an effort to prevent, rather than punish, those sorts of
crimes. Id.
59

The United States Food and Drug Administration, The Possible Dangers of Buying
Medicines Over the Internet, http://www.fda.gov/ForConsumers/ConsumerUpdates/
ucm048396.htm (last visited Feb. 12, 2009); Drug Enforcement Administration, Office of
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recommends that the pharmacy should be licensed, located in the United States,
require a prescription, and have a pharmacist available for any questions or
concerns.60 In a similar vein, the DEA advises consumers on common traits of
unsafe websites.61 Unsafe websites are often eager to offer to import illegal or
dangerous drugs without a valid prescription.62
B. An analysis of The Ryan Haight Online Pharmacy Consumer Protection Act of
2008
The Ryan Haight Act addresses several issues. Primarily, the Act adds to and
amends several sections of the Controlled Substances Act.63 The additions and
amendments are specifically directed towards online pharmacies.64 These additions
are significant because the Ryan Haight Act is really the first piece of major
legislation to address online pharmacies directly. The Act reflects both a change in
environment and legislative direction. 65
The DEA’s press release highlights six prominent features of the Act,66 which
will be discussed in depth later in the note. The Act will: (1) require face to face

Division Control, Questions and Answers: Dispensing and Purchasing Controlled Substances
Over the Internet http://web.archive.org/web/20080722205257/http://www.dea diversion.
usdoj.gov/faq/internetpurch.htm (last visited Apr. 15, 2010).
60
Drug Enforcement Administration, Office of Division Control, Questions and Answers:
Dispensing and Purchasing Controlled Substances Over the Internet, http://web.archive.org/
web/20080722205257/http://www.deadiversion.usdoj.gov/faq/internetpurch.htm (last visited
Apr. 15, 2010).
61

Id.

62
Id. The DEA provides notice of the laws relevant to importing controlled substances
with “The Controlled Substances Act prohibits any person from importing into the customs
territory of the U.S. any controlled substance or List I chemical (21 U.S.C. § 971) and (21
CFR part 1313) unless that person maintains a valid, current authorization to import such
substances or chemicals (21 U.S.C. 957(a)). Illegal importation of controlled substances is a
felony that may result in imprisonment and fines (21 U.S.C. 960). Id.
63
110 P.L. 425 (Oct. 15, 2008).
The Ryan Haight Act amends 21 U.S.C. § 801, 21
U.S.C. § 802, 21 U.S.C. § 823, 21 U.S.C. § 827, 21 U.S.C. § 829, 21 U.S.C. § 831, 21 U.S.C.
§ 841, 21 U.S.C. § 843, 21 U.S.C. § 882, and 21 U.S.C. § 960. Id.
64
See generally 21 U.S.C. § 831 et seq; Mike Pramik, New Law regulates internet drug
sales, The Columbus Dispatch, http://www.columbusdispatch.com/live/content/business/
stories/2008/10/17/Internet_pharmacy_law.ART_ART_10-17-08_C12_SUBKEQK.html?sid=
101 (last visited Mar. 25, 2009). “Before the law was enacted, the legal definition of what
constitutes a prescription had been left to state pharmacy boards.” Id.
65

110 P.L. 425 (Oct. 15, 2008). While the legislation places online pharmacies on the
same regulatory regime as brick and mortar pharmacies, it includes many internet specific
provisions. Id.
66
DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act,
http://www.prweb.com/releases/DEA/Pharmacy_Act/prweb1409764.htm (last visited Dec. 2,
2008). At the time of the press release, the Act had not been formally signed into legislation
by President Bush. DEA Administrator Michele Leonhart stated "[t]his landmark piece of
legislation will bring rogue pharmacy operators out of the shadows by establishing a clear
standard for legitimate online pharmaceutical sales. The legislation will allow customers to
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medical examination before a prescription is issued, (2) require DEA endorsement
for pharmacies, (3) increase penalties for distributing certain drugs, (4) prohibit
advertising illegal drug sales, (5) require pharmacies to post relevant contact
information, and (6) create a civil cause of action for state attorneys general.67
1. Strengths of the Ryan Haight Act
2. DEA Endorsement68
Under the Controlled Substances Act, brick and mortar pharmacies that dispense
Schedule II, III, IV, or V drugs69 must register with the Drug Enforcement
Administration70 and state attorney generals. Before the Ryan Haight Act, online
pharmacies were not required to register with the DEA. Online pharmacies were
only required to register the “actual physical location of the pharmacy which
purchases, stores and dispenses controlled substances pursuant to prescription orders
processed by the Internet site.”71 Now, the DEA contends that online pharmacies will
be put on “equal footing” with brick and mortar pharmacies by the Act because all
DEA “shall modify the registration of pharmacies . . . to dispense controlled
substances by means of the internet.”72
know they are doing business with a trusted, legitimate pharmacy, and give law enforcement
the tools we need to identify illegitimate online pharmacies." Id.
67

Id.

68

21 U.S.C. § 823 (b) (2008). Pharmacies registered to dispense controlled substances
will have their registrations modified to “authorize them to dispense controlled substances by
means of the internet”. Id.
69
Dispensing and Purchasing Controlled Substances over the Internet, supra note 26, at
21181.

“Schedule II - Amphetamine, codeine, fentanyl, Hydromorphone, meperidine, methadone,
Methylphenidate (Ritalin),morphine, oxycodone, pentobarbital, phencyclidine(PCP),
secobarbital.
Schedule III - Anabolic steroids, phendimetrazine, and productsthat contain small
quantities of certain schedule II controlled substances, such as codeine, in combination with
noncontrolled ingredients, such as aspirin.
Schedule IV - Alprazolam (Xanax), chlordiazepoxide (Librium),diazepam (Valium),
lorazepam (Ativan), phenobarbital, phentermine.
Schedule V- Buprenorphine and many cough Preparations that contain a limited amount of
codeine.”
70

21 U.S.C. § 823 (2006). This section of the Controlled Substances act also allows for
distributor and manufacturers to forego the registration requirements in the name of public
interest.
71
21 U.S.C. § 823 (b) (2008); Dispensing and Purchasing Controlled Substances over the
Internet, supra note 26, at 21182.
72

DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act,
supra note 66. Online pharmacies are put on equal footing with brick and mortar pharmacies
for regulatory purposes. The Ryan Haight Act includes several internet specific provisions to
facilitate the “equal footing”. Id.

124

JOURNAL OF LAW AND HEALTH

[Vol. 23:29

The problem before the legislation was evident in the relationship between the
online pharmacies and the registered brick and mortar pharmacies. The registered
pharmacies would “have little or no walk-in customers and do most or all of their
business via rogue Internet sites.”73 This relationship enabled online pharmacies to
bypass traditional methods of regulation. Traditional DEA regulation would monitor
entities that dispensed the controlled substances for violations of the law. Before the
Act, online pharmacies had full access to DEA regulated controlled substances
without being registered with the DEA. In other words, many of the pharmacies
were simply off or under the radar of the regulating agencies.
Pharmacist Tommy Fuchs presents a vivid illustration of the need for the federal
registration requirement. Fuchs established brick and mortar pharmacies in Texas
and later in Oklahoma as front for his online pharmacy businesses.74 Fuchs’ online
pharmacies, in turn, were merely a way to sell pain pills to addicts at an enormous
profit. At their peak, the pharmacies filled up to 500 prescriptions for controlled
substances from the same doctor each day.75 The prescriptions commonly authorized
the maximum number of refills, which allowed the consumer to receive as many pills
as he or she wanted at a time and the pharmacy to make more money per
transaction.76 Unfortunately, one of the prescriptions and refill combinations went to
Ryan Haight, who was killed from an overdose of the medicine.77
Fuchs’ original Texas pharmacy had been shut down by the Texas State Board of
Pharmacy after the Board noticed a suspiciously high number of prescriptions were
filled by the same doctor.78 The Texas Board took all of the necessary action it was
authorized to do.79 Confined to act under laws designed to regulate brick and mortar
pharmacies, the Texas Board was largely unable to prevent series of events that
followed. Undeterred, Fuchs simply hopped the state line and picked up where he

73

Id.

74

United States v. Fuchs, 467 F.3d 889,898 (5th Cir. 2006). Fuchs paid staff physicians
between $40 and $70 for each prescription. Id.
75

Id.

76

Id.

77

Testimony of Francine Haight: Hearing before the S. Comm. On the Judiciary, 110th
Cong. (May 16, 2007), available at http://judiciary.senate.gov/hearings/testimony.cfm?id=275
5&wit_id=6466 (last visited Feb. 12, 2009). Francine Haight, Ryan Haight’s mother, testified
before the Judiciary Committee. In her testimony, Francine relived the events leading up to
Ryan’s death, stating “Clayton Fuchs of Mainstreet Pharmacy, delivered [the drugs] to our
home.” Francine also read excerpts from letters she has received expressing public support for
online pharmacy regulation. Id.
78

Fuchs, 467 F.3d at 897. “Texas State Board of Pharmacy performed a routine
inspection of [Fuchs’ pharmacy] . . . [and] was troubled by the high volume of prescriptions. .
. [and] also concerned that nearly all . . . prescriptions were signed by the same doctor, who
was located in Texas, [although his] patients were dispersed throughout the United States.”
Id.
79

Id. The Texas Board of Pharmacy Field Compliance Officer “informed Fuchs that the
prescriptions generated through [the website] were invalid.” Id.
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left off.80 One month after being shut down in Texas, Fuchs opened an Oklahoma
pharmacy under a different pharmacy name. The Oklahoma pharmacy functioned in
the nearly the exact manner as the Texas pharmacy - peddling drugs under a quasilegal entity.81 The pharmacies generated millions of dollars and Fuchs fueled
addictions across the country by prescribing and shipping pills to whomever was
willing to pay.
The federal registration requirement is a much needed element of federal
regulation. The registration requirement in the Ryan Haight Act could have
prevented the conduct described above. By requiring all internet sites to register, the
DEA would be better able to monitor online pharmacies for illegitimate use.82
Rather than searching the internet and investigating individual web sites, the DEA
could now simply shut down any unregistered site as soon as it is discovered,
precluding nefarious pharmacists from crossing state lines, opening a new pharmacy
and resuming business as usual.
The nature of the internet is far more conducive to federal regulation than state
regulation. The internet is the same for all users, regardless of whichever state a
particular user happens to be a part of. Federal agencies are not bound by arbitrary
lines – they are free to regulate across all fifty states. The DEA endorsement could
also serve as a central database of valid online pharmacies. Ideally, all valid
websites would be readily ascertainable in one centralized source, perhaps setting the
foundation for cooperation with other government agencies and business entities.
Perhaps eventually a published list of DEA endorsed online pharmacies will be
available to consumers as to promote safe online transactions. The ability to check
the endorsement status of a website may be very reassuring to new or inexperienced
online patrons.
a. Transparency and Notice
An additional strength of the Ryan Haight Act is that the Act itself serves as a
notice of the government’s position on online pharmacies to the public. The
underlying theme of the government’s message is that all pharmacies will be held
accountable to the same regulations and standards, notwithstanding their status as a
digital or brick and mortar entity.83 For consumers, the Ryan Haight Act strives to
80

Id. A field compliance officer from the Texas State Board of Pharmacy performed an
inspection of Fuchs’ pharmacy in August of 2000. Id. The officer was troubled by the amount
of prescriptions and the practice of having the same Texas doctor prescribe patients
throughout the United States. Id. The officer informed Fuchs that the prescriptions were
invalid. Fuchs subsequently closed the Texas pharmacy. Id. In October 2000, just three short
months after closing the original pharmacy, Fuchs opened his Oklahoma pharmacy. Id.
81

“[the Oklahoma pharmacy’s] operation was substantially the same as [the Texas
pharmacy].” Id. at 898. “The pharmacy was processing between 300 and 500 prescriptions
per day, approximately 70% of which were for hydrocodone. And nearly every . . . order was
shipped out was a 30 day supply of 100 tablets with two refills.” Id.
82

DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act,
supra note 66.
83
DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act,
supra note 66. The act will place online pharmacy sales “on an equal regulatory footing with
those sales through a brick-and-mortar facility. The act requires an endorsement of an existing
registration to allow existing pharmacies to sell controlled substances online . . . [L]aw
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place online pharmacies on equal footing with brick and mortar pharmacies in terms
of transparency, customer service and compliance with relevant laws.84 The Ryan
Haight Act requires pharmacy websites to disclose information so commonplace in
brick and mortar pharmacies that it may often go unnoticed. For example, online
pharmacies are now required to place contact and licensure information prominently
on the home page.85 Increased transparency will ease the consumer concerns
regarding the legality86 of the pharmacy and establish consumer trust. While this
aspect of the Ryan Haight Act will not deter criminals from trying to bypass
controlled substance regulations, it will help consumers avoid falling prey to rogue
website fraud.
For prescribing doctors and pharmacists, the Ryan Haight Act serves as a notice
of baseline professional conduct and as a warning for those who choose to act
outside of professional conduct. The Ryan Haight Act requires a valid prescription
before any controlled substance is dispensed.87 A valid prescription requires at least
one in-person medical evaluation,88 putting an end to remote consultation pharmacies
as commonly practiced. Remote consultation pharmacies relied on the doctor’s
ability to issue prescriptions to whoever is willing to fill out a website
questionnaire.89 Through the use of a questionnaire, one doctor was able to provide
service to countless customers from all over the United States, keeping the cost of
operating an online pharmacy to a minimum.90 It is clear that legislators believe the
potential harm from remote consultation pharmacies outweighs the possible benefits
of lower cost and at-home service.
The Ryan Haight Act will change the willingness and ability of pharmacists and
physicians to dispense drugs illegally.
Pharmacists and doctors that ignore
minimum guidelines do so at their own peril. Anyone caught violating the
Controlled Substances Act will face steeper penalties than before.91 The scope of
enforcement will be able to . . . scrutinize all applications for such registration . . . easily
separate . . . illegitimate Internet operations.” Id.
84

21 U.S.C. §§ 831(c)(1-7) (2008) . Online pharmacies are required to “post in a visible
and clear manner” the name and address of the pharmacy, the pharmacy’s telephone number
and email address, the name and degree and states of licensure of the pharmacist in charge, a
list of states in which the pharmacist is licensed, and a certification that the pharmacy is
registered to deliver, distribute, or dispense controlled substances over the internet. Id.
85

21 U.S.C. §831(c)

86
Dispensing and Purchasing Controlled Substances over the Internet, supra note 26 at
21183. Under the heading “Are Internet Pharmacy Sites Legitimate?” the DEA encourages
readers to confirm the legitimacy of any internet site before filling or ordering a prescription.
87

21 U.S.C. § 829 (2008).

88

Id. “The term ‘valid prescription’ means a prescription that is issued for a legitimate
medical purpose in the usual course of professional practice by -- a practitioner who has
conducted at least 1 in-person medical evaluation of the patient. . . ” Id.
89

See Ancier, supra note 15.

90

Id. at 836. A remote consultation pharmacy is able to serve thousands of consumers
from all over the United States through one doctor. Id.
91

21 § U.S.C.(b)(C, E).
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punishable offenses under the Controlled Substances Act applies to all stages of
participation in an online pharmacy – from writing the prescriptions to serving as an
intermediary for buyers and sellers.92 DEA Administrator Michele Leonhart
concludes that “[t]he legislation will allow customers to know they are doing
business with a trusted, legitimate pharmacy.”93
b. Striking a Balance between State and Federal Authority94
The Ryan Haight Act creates a state cause of action to better protect consumers
and regulate online pharmacies.95 The problem before the Act was that “a state
Attorney General's enforcement authority against an online pharmacy is limited to
the geographic boundaries of that state, which causes significant challenges when a
case involves illegal activity over the Internet.”96 Traditionally, pharmacies are
regulated by state law while medicine is regulated by federal agencies. States
regulate pharmacies through practice licensure. Once licensed by a particular state,
pharmacies and pharmacists may dispense FDA regulated or DEA controlled
substances.97
The state cause of action “allows states to work together with each other and with
the federal government to strike the correct balance that will afford consumers the
greatest protection without eliminating the states’ traditional role in pharmacy

Schedule III: Maximum sentence for first offenders from 5 years to 10 years;
Maximum sentence for second offenders from 10 years to 20 years;
Schedule IV: Maximum sentence for first offenders from 3 years to 5 years;
Maximum sentence for second offenders from 6 years to 10 years;
Schedule V: Maximum sentence for second offenders from 2 years to 6 years.

92

21 U.S.C. § 841 (2008). The Ryan Haight Act prohibits delivery and distribution of
controlled substances by means of the internet, unless authorized by the DEA. Some
examples of delivery and distribution provided by the Act are “writing a prescription for a
controlled substance for the purpose of delivery, distribution, or dispensation by means of the
Internet” and “offering to fill a prescription for a controlled substance based solely on a
consumer's completion of an online medical questionnaire.”
93

DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act,
supra note 66.
94

21 U.S.C.§ 882 (2008). “The State shall serve a copy of the complaint upon the
Attorney General and upon the United States Attorney . . . Upon receiving notice respecting a
civil action pursuant to this section, the United States shall have the right to intervene in such
action”. Id.
95

Id.

96

DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act,
supra note 66.
97
Hearing on Internet Drug Sales before the H. Comm. On Government Reform, 108th
Congress (2004) (statement of William K, Hubbard, Associate Commissioner for Policy and
Planning.
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licensing and regulation.”98 Under the Act, any state that has reason to believe its
residents may be adversely affected by an online pharmacy may bring civil action on
behalf of state residents. 99 The civil action includes injunctive relief, damages, and
enforcing compliance.100 The Act also allows for federal intervention if
appropriate.101 The cooperation between state and federal government encourages
flexibility necessary to regulate dangerous online entities. State governments may be
more able to become aware of a problem pharmacy more quickly than the federal
government, but the federal government’s resources may be more effective in
combating the problem.
3. Where the Ryan Haight Act falls short
a. Unnecessary legislation
Unfortunately, much of the Ryan Haight Act is dedicated to unnecessary
legislation. In a press statement released when the Act was passed, the DEA touts
six areas of the controlled substances act that are amended by the Ryan Haight Act
that were intended to address the problems caused by online pharmacies.102 In
reality, the Act does not do much in respect to combating rogue and remote
consultation pharmacies in at least three of the areas highlighted by the DEA. Those
areas are the face–to-face requirement for valid prescriptions, a ban on advertising,
and increased penalties for violating the act.
Perhaps one of the most mentioned features of the Act requires a face-to-face
meeting between the prescriber and the patient.103 The Act also prohibits advertising
or offering to fill a prescription based solely on a questionnaire.104 In 2001, the DEA
published a notice to establish guidelines for dispensing and purchasing controlled
substances over the internet.105 In the notice the DEA stated that “[c]ompleting a

98

Clifton, supra note 5, at 567.

99

21 U.S.C.§ 882 (2008).

In any case in which the State has reason to believe that an interest of the residents of
that State has been or is being threatened or adversely affected by the action of a
person, entity, or Internet site that violates the provisions [The Controlled Substances
Act], the State may bring a civil action on behalf of such residents in a district court of
the United States with appropriate jurisdiction.
100

Id.

101

Id.

102

See Press Release, DEA, supra note 66.

103

21 U.S.C. § 829 (2008). “No controlled substance that is a prescription drug as
determined under the Federal Food, Drug, and Cosmetic Act may be delivered, distributed, or
dispensed by means of the Internet without a valid prescription.” A valid prescription requires
“at least 1 in-person medical evaluation of the patient”. Id.
104
21 U.S.C. § 841 (2008). The text of the Ryan Haight Act prohibits “offering to fill a
prescription for a controlled substance based solely on a consumer's completion of an online
medical questionnaire”. Id.
105

Dispensing and Purchasing Controlled Substances over the Internet, supra note 26.
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questionnaire that is then reviewed by a doctor hired by the Internet pharmacy could
not be considered the basis for a doctor/patient relationship.”106
In 2005, the DEA released another publication addressing online pharmacies.107
More specifically, the publication was an attorney’s bulletin explaining why remote
consultation pharmacies are illegal.108 Further, the bulletin offers advice to
prosecutors on successful theories of prosecution in combating remote consultation
pharmacies.109 The illegality of remote consultation pharmacies had been established
for nearly a decade before the Act’s effective date.
Case law also suggests that the face-to-face meeting requirement in the Act is
redundant. In United States v. Nelson, a doctor employed by a remote consultation
pharmacy was convicted of “conspiracy to distribute controlled prescription drugs
outside the usual course of professional practice, in violation of 21 U.S.C. § 846”
after filling prescriptions without a face to face meeting with his patients.110 The
physician, Nelson, would review patient records and sign the prescriptions as
required by federal law. As online consumers filled out questionnaires and requests
for prescription drugs, Nelson went to the actual brick and mortar location of the
pharmacy to conduct a review of the orders, never speaking or meeting any of the
consumers who had placed the order. Some days, Nelson would review up to a
thousand questionnaires.111 Nelson received compensation for “reviewing” the
questionnaires from the owner of the pharmacy. Nelson’s conduct was essentially
equal to that of a drug dealer. Customers came to him for drugs, and for a fee, he
would aid them in obtaining them. Nelson’s conduct resulted in a conviction for a
violation of the Controlled Substances Act.112
106

Id. at 21183.

107

Id.

108

See generally id.

109

Charlotte J. Mapes, Internet Pharmacies and the Unlawful Distribution of Controlled
Substances, United States Attorney’s Bulletin, Volume 53 Number 5, September 2005
available at http://www.usdoj.gov/usao/eousa/foia_reading_room/usab5305.pdf.
In the
introduction to the step-by-step advice on how to prosecute online pharmacy operators, the
author states that the Food, Drug, and Cosmetic Act and the Controlled Substances Act are
used to prosecute drug distributors even though the internet was not in existence at the time of
legislation. Mapes proceeds to explain successful prosecution techniques. Mapes concludes,
“Internet pharmacy cases are being successfully prosecuted by Untied States Attorney’s
Offices around the country. Such prosecutions can have a substantial impact on the
availability of these dangerous drugs. . . .” Id.
110
United States v. Nelson, 383 F.3d 1227 (10th Cir. Okla. 2004) (held that “the
government presented sufficient evidence from which a reasonable jury could find beyond a
reasonable doubt that Nelson participated in a conspiracy to distribute prescription drugs
outside the usual course of professional practice”).
111

Mapes, supra note 109. Nelson reviewed “exponentially more [prescriptions] than he
could have written if he had seen and consulted with each patient before issuing a
prescription.”
112
Id. Nelson, a physician, was convicted for conspiracy to distribute controlled
prescription drugs outside the usual course of professional practice over the internet. Nelson
approved over up to 95% of all internet prescriptions without ever physically examining his
patients. The vast majority of the prescriptions were for schedule III painkillers. Nelson
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The court in Nelson used the very same statute the Ryan Haight Act amends to
convict an internet pharmacist.113 Nelson’s conviction was based on a violation of
laws established for brick and mortar pharmacists “acting outside the usual course of
professional practice.”114 The violation of this standard was due in large part to his
failure to conduct face-to-face meetings with his patients. Several years later,
Congress eventually passed legislation that required the face-to-face meeting in an
effort to regulate rogue pharmacies. By adding redundant and already established
requirements, the Ryan Haight Act does not contribute in a meaningful way to
improve online pharmacy regulation.
In United States v. Fuchs, a pharmacist was convicted under the Controlled
Substances Act for his participation in a remote consultation pharmacy for
dispensing controlled substances via the internet to customers who received
prescriptions based solely on questionnaires.115 Fuchs operated a remote consultation
pharmacy where customers from anywhere in the United States could place orders
for prescription medication through the use of a questionnaire.116 Once the
questionnaires were complete, a prescription form was automatically created and
sent to the on staff physician.117 After a cursory review, the physician would sign the
form and authorize the prescription. Fuchs paid the physician forty dollars for each
signed prescription form.118 Fuchs’ website was, in essence, a method for consumers
to bypass traditional restrictions on controlled substances for a small fee, much like
that of a street corner drug dealer.119
United States v. Lovin includes a discussion regarding dispensing controlled
substances to customers who completed a questionnaire via the internet when the
Ryan Haight Act was still pending legislation.120 The Lovin court concluded that the
played an integral role in the rogue pharmacy scheme. As the prescribing physician, Nelson
personally signed thousands prescriptions to authorizing the pharmacy to distribute the
painkillers. Id.
113

Id.

114

United States v. Moore, 423 U.S. 122, 124 (1975).

115

Fuchs, 467 F.3d 889, 898-899 (upholding conviction for conspiracy to distribute
controlled substances).
116
Id. “Customers located throughout the United States went to the pharmacy's web site,
completed an online profile, and requested medication . . . [the doctor] reviewed the patient's
profile and approved and signed the prescription without communicating with the patient
either face to face or over the telephone.” Id. at 897.
117

Id.

118

Id. Fuchs eventually increased the payment to online pharmacy doctors to 100 dollars
per prescription after the size of the prescription was changed from 40 pills to 100 pills. Id. at
897.
119

DEA News: Congress Passes Ryan Haight Online Pharmacy Consumer Protection Act,
supra note 66. “Rogue Internet pharmacies typically operate with active participation of an
unscrupulous doctor who willingly issues prescriptions to "patients" throughout the country
whom the doctor never sees and without a preexisting bona fide doctor-patient relationship.”
Id.
120

United States v. Lovin, 2008 U.S. Dist. LEXIS 80258, at *10-13 (S.D. Cal. Sept. 29,
2008) (Citing Quinones, 536 F. Supp. 2d at 273).
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indictment for violations of the Controlled Substances Act were valid even as
legislation directly addressing the issues at hand sat unpassed in Congress, stating
"[t]hat [even though] Congress has considered clearer legislation . . . does not mean
that existing laws do not apply. . . ."121 Lovin, Fuchs, and Nelson demonstrate that
participation in the operation of a remote consultation pharmacy is a violation of the
Controlled Substances Act. Formal legislation reaching this conclusion does not
provide internet consumers any additional protection. Some commentators are now
advocating that the passage of the Ryan Haight Act indicates that remote
consultation was previously legal and that current indictments should be thrown
out.122 Legislators needed to expand and build on the scope of the existing online
pharmacy regulation.
Additionally, the increased penalties in the Act seem largely irrelevant. The
increase in prison time is irrelevant largely in part to the scale of the online pharmacy
operations. “Stiffer penalties on the sellers of these drugs will not make an
appreciable dent in Internet sales. Most of the Web sites offering these drugs are
hosted outside the United States, with the sellers well beyond the reach of U.S. law
enforcement.”123 Successful online pharmacy prosecutions also often result in a wide
array of criminal charges. Convictions for conspiracy, money laundering, and
continuing criminal enterprise have all accompanied online pharmacy violations of
the Controlled Substances Act.124
b. Failure to address Crucial Aspects of Online Pharmacies
Although generally well received, the Act has generated some criticism.125
Perhaps the largest weakness in the Ryan Haight Act is the failure to address
important aspects of the online pharmacy industry. Some of the omissions in the Act
seem to suggest that the legislators lacked a fundamental understanding of the
problems associated with online pharmacies and how they affect consumers. Many
of these problems and issues are well documented with private enterprises that rate
the validity of online pharmacies.126 The Ryan Haight Act fails to address
requirements regarding patient privacy, foreign pharmacies, search engines, and noncontrolled substances.
The Ryan Haight Act fails to address any sort of financial or medical record
requirement for websites. Identity theft, fraud, and patient privacy are among the
first concerns that come to mind for any online transaction, especially when dealing
with health issues. While striving to regulate online pharmacies in the same manner
121

Id. at *12.

122

See generally Donald Cooley, supra note 20.

123

Mathea Falco and Philip Heymann, Fighting the Online Drug Corner, Washington
Post, Mar. 15, 2008, at A13.
124

Mapes, supra note 109.

125
Sarah Rubenstein, New Bill Targets Rogue Druggists on the Internet , WALL ST. J.,
Oct. 9, 2008, at D1, available at http://online.wsj.com/article/SB122351521815117817.html
?mod=googlenews_wsj (last visited Oct. 31, 2009).
126
National Association of Boards of Pharmacy, http://www.nabp.net/ (last visited Dec.
5, 2008). Pharmacy Checker.com, http://www.pharmacychecker.com/aboutop.asp (last visited
Dec. 5, 2008).
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as brick and mortar pharmacies, legislators have overlooked problems unique to the
internet.
Unregulated medication from foreign pharmacies also poses a threat to
consumers. Imported medication may be counterfeit, mislabeled, unsafe, or
manufactured under dissatisfactory conditions.127 Non-controlled substances, often
called “lifestyle drugs”128 include hair growth, weight loss, and sexual enhancement
medication. Lifestyle drugs do not pose the threat of addiction presented by
controlled substance but may still be dangerous if left unregulated.129
Finally, the Act bans the use of the internet to “advertise the sale of, or to offer to
sell, distribute, or dispense a controlled substance.”130 This provision is a good start,
but seems to indicate a lack of understanding from the legislators. Google, a leading
online advertiser, has already placed self imposed bans on advertising dangerous
online pharmacies.131 Rather, the legislators should have attempted to regulate
search engines, which lead consumers to dangerous online pharmacies without the
need for the banned advertisements.
IV. RECOMMENDATIONS FOR FUTURE LEGISLATION
Based on the analysis above, the Ryan Haight Online Pharmacy Consumer
Protection Act must be amended in order to protect consumers. Future legislation
targeted at online pharmacy consumer protection must include regulations for search
engines and web intermediaries, patient privacy, foreign pharmacies, lifestyle drugs
and drug manufacturers.
A. Web Intermediaries
The Ryan Haight Act appears to ignore the very medium that supports online
pharmacies- the internet. Although the Act now allows webhosts to shutdown
pharmacies that are not properly registered with the DEA,132 I recommend that
future legislation place more responsibility and accountability with web hosts, search
engines, and credit card companies. Domain registration companies have expressed

127
United States Food and Drug Administration, http://www.fda.gov/oc/initiatives/
counterfeit/qa.html (last visited Dec. 5, 2008).
128

Dispensing and Purchasing Controlled Substances over the Internet, supra note 26 at

21184.
129

Kansas ex rel. Stovall v. ConfiMed.com, L.L.C., 38 P.3d 707 (Kan. 2002) (Kansas
failed to prosecute a Washington doctor under the Kansas Consumer Protection Act after
Viagra, a sexual enhancement drug, was delivered to a 16 year old. The trial court stated “I
don’t have any trouble with saying. . . . these people ought to be de-frocked as medical
practitioners, as pharmaceutical practitioners. . . ”).
130

21 U.S.C. § 843 (2008).

131

Google, Online Pharmacy Qualifications, http://www.google.com/adwords/pharmacy_
qualification.html (last visited Dec. 5, 2008). “Google only accepts online pharmacies that are
based in the U.S., Canada, the UK, the Republic of Ireland, Germany, the Netherlands,
Australia, or New Zealand and have met certain conditions.”
132

A.J. Perez, New law allows website hosts to just say no to drug, USA TODAY, Oct. 24
2008, at C7.
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support133 for the Ryan Haight Act and even “proposed modifications to make the
legislation more relevant”.134
In testimony to Congress, William K. Hubbard praised the practices of Google,
Yahoo!, Microsoft, and America Online for their voluntary efforts to combat the
prevalence of rogue online pharmacies.135 He further stated that the FDA has
encouraged the cooperation of major online search engines and will continue to do
so.136 The need to regulate web intermediaries and other internet sales facilitators is
well documented. Consumers will not be adequately protected from the ills of
internet pharmacies without this crucial step.
Former assistant secretary of state for International Narcotics Matters, Mathea
Falco, described the complexity and depth of the role that web intermediaries play by
stating
[R]ogue pharmacies operating in lawless locations will continue offering
to sell narcotics to teenagers without prescriptions -- or with the phoniest
pretense of a prescription -- happily using the unwitting cooperation of
U.S. search engines, Internet service providers and credit card companies.
We need additional legislation to require the legitimate businesses that are
key intermediaries in illegal online drug transactions to withdraw their
assistance.137
Falco’s concerns with web intermediaries are well founded. Legislation should be
established that will either penalize intermediaries that assist illegal online drug
transactions or provide incentives to intermediaries that actively resist or take steps
to avoid aiding illegal online transactions. Falco offers a solution that combines
elements of consumer education and reliance on new technology that would impose
relatively simple requirements on search engines:
Search engines that profit from [online pharmacies offering controlled
substances] -- should automatically provide a banner warning that such
purchases are illegal and describing the dangers of the drugs whenever
searches for such terms are requested. In addition, Internet service
providers should, in a highly public way, offer customers the use of spam
filters to exclude from their homes offers for illegal sales of any controlled
substance, such as prescription narcotics.138
Falco’s solution protects internet consumers who may unknowingly break the law
while offering parents a solution to prevent the sort of behavior that killed Ryan
133

Id.
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Go Daddy Cheers Passage of Online Pharmacy Legislation, Drug Week, Apr. 18,

2008.
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Hearing on Internet Drug Sales before the H. Comm. On Government Reform, 108th
Congress (2004) (statement of William K, Hubbard, Associate Commissioner for Policy and
Planning, supra note 45.
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Id.
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Mathea Falco and Philip Heymann, Fighting the Online Drug Corner, WASHINGTON
POST, Mar. 15, 2008 at A13.
138
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Haight. The filter would act as a barrier to prevent interested parties from pursuing
or following through on advertisements from rogue pharmacies.
B. Patient Privacy
Patient privacy is especially important in online transactions because often, the
consumer faces a greater risk of financial or medical data being accessed by a third
party than if the consumer were at a local brick and mortar pharmacy. The National
Association of Boards of Pharmacy offers two suggestions for consumers when
choosing an online pharmacy based on patient privacy. First, the website should
encrypt any material that may identify the patient. Next, the website should provide
patients with a Notice of Privacy Practices for Protected Health Information. Future
legislation should require online pharmacies to encrypt financial and medical
information and provide privacy notices.139
Two larger online pharmacies, CVS and Walgreens, have extensive sections of
their websites responding to patient privacy concerns.140 Walgreens, for example, is
relatively open about what information is disclosed to whom.141 Walgreens’ patient
privacy policy also suggests that Walgreens has a relatively firm grasp on the patient
privacy risks associated with the internet. Perhaps more importantly, Walgreens
provides contact information for consumers who may have further inquiries and
methods to opt out of some information disclosure programs.142 The CVS privacy
policy is quite similar to that of Walgreens.143 CVS explains its policies regarding
protecting and sharing information gathered from website visitors, provides contact
information, and how it uses the information.
Future online pharmacy patient legislation should draw heavily from existing
patient privacy policies of successful and respected pharmacies. Three notice
requirements that should be formally legislated are a notice of how the information is
stored and used, what information is collected, and to whom what information is
disclosed. Additionally, online pharmacies should be required to educate consumers
about how their privacy rights may be affected through use of the site that may be
different from privacy rights in a traditional pharmacy setting, such as “visits to the
Site, which parts of the Site visitors select, IP address (the Internet address assigned

139

National Association of Boards of Pharmacy, supra note 126.

140

CVS/pharmacy, Help: Privacy Policy, http://www.cvs.com/CVSApp/help/privacy_
policy.jsp (last visited Feb. 12, 2009); Walgreens, Walgreens.com Online Privacy & Security
Policy, http://www.walgreens.com/help/privacyandsecurity.jsp (last visited Feb. 12, 2009).
141

Walgreens, Walgreens.com Online Privacy & Security Policy, http://www.walgreens.
com/help/privacyandsecurity.jsp (last visited Feb. 12, 2009). “Categories of personally
identifiable information include: name, address, phone number, e-mail address, date of birth,
billing/shipping information (credit card number, shipping address), and Rx number.” Id.
142

Id. “You can always choose not to provide information.” Walgreens also provides
relevant contact information for consumers who have additional concerns. Id.
143
CVS/pharmacy, Help: Privacy Policy, http://www.cvs.com/CVSApp/help/privacy_
policy.jsp (last visited Feb. 12, 2009). “We want you to understand how any personally
identifiable information you provide to us is collected and used. Your personally identifiable
information is removed before collected information is passed to the database we use to
generate reports.” Id.
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to your computer from your Internet Service Provider), domain type, browser type
(e.g., Netscape or Internet Explorer), date and time of day.”144
Finally, legislation should establish a standard by which all online pharmacies
must protect patient privacy. CVS claims to use “reasonable measures”145 to protect
patient privacy. Reasonable measures, according to CVS, include the use of “Secure
Socket Layer (SSL) technology . . . SSL technology provides for the safe
transmission of personal information . . . because the information is encrypted.
Encryption involves systematically scrambling numbers and letters so that if
someone managed to intercept a packet of information, they would not be able to
make sense of it.”146 Legislators should implement a flexible patient privacy
protection standard for online pharmacies that allows for and anticipates the
development of more powerful technology. The standard protection must at least
use reasonable encryption methods to protect online pharmacy patients in future
legislation.
C. Foreign Pharmacies
Foreign pharmacies are particularly troublesome because they are not subject to
U.S. laws and regulations. Imported drugs can be especially dangerous.147 The FDA
estimates that up to 30% of imported drugs may be counterfeit.148 Counterfeit
medicine is dangerous simply because consumers may be unknowingly taking life
threatening substitutes. For example, the FDA discovered that many consumers who
ordered Ambien, Xanax, Lexapro, and Ativan from online pharmacies received
products that actually contained haloperidol.149 The FDA describes haloperidol as “a
powerful anti-psychotic drug.”150
In 2004, the FDA took “action against three foreign internet sites associated with
a site previously found to be selling counterfeit contraceptive patches that contain no

144

CVS.com Privacy Policy, http://www.cvs.com/CVSApp/help/privacy_policy.jsp (last
visited Apr. 15, 2010).
145
146

Id.
Id.
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United States Food and Drug Administration, http://web.archive.org/web/20080223
155318/http://www.fda.gov/oc/initiatives/counterfeit/qa.html (last visited Apr. 15, 2010).
148

Id. United States Food and Drug Administration, http://web.archive.org/web/2008022
3155318/http://www.fda.gov/oc/initiatives/counterfeit/qa.html (last visited Apr. 15, 2010).
The prevalence of counterfeit drugs in developed countries is estimated to be as low as 1%.
The FDA asserts that the prevalence of counterfeit drugs in the United States is lower that 1%,
not withstanding two recent and highly publicized incidents.
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The United States Food and Drug Administration, The Possible Dangers of Buying
Medicine Online, supra note 58. The side effects for haloperidol are quite serious. The FDA
reports that “some sought emergency medical treatment for symptoms such as difficulty in
breathing, muscle spasms and muscle stiffness.” The FDA has compiled a list of drugs that
consumers should not purchase online due to safety restrictions at www.fda.gov/cder/
consumerinfo/dontBuyonNet.htm. Id.
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active ingredients.”151 The counterfeit patches did not provide any protection against
pregnancy. Although outside the jurisdiction of the United States, the FDA was not
helpless.152 The FDA “obtained the cooperation of the U.S.-based internet service
provider in shutting down service to these sites.”153 On its own initiative, the FDA
utilized appropriate web intermediaries to remove the foreign threat.
The FDA has taken measures beyond consumer education and internet service
provider cooperation. The FDA also began issuing “cyber letters” in 2000.154 In a
press release, the FDA explains that the cyber letters are
electronic versions that are similar to traditional "warning" or "untitled"
letters, which the agency has long sent to organizations or individuals it
believes are engaged in violative activities. These letters usually outline
the nature of the alleged violation and request a formal response [and] also
provide[s]… foreign operators with an explanation of the statutory
provisions that govern interstate commerce of drugs in the United States,
as well as a warning that future shipments of their products to this country
may be automatically detained and subject to refusal of entry.”155
Not only are drugs from foreign based online pharmacies more likely to be
counterfeit or unsafe,156 they are often more expensive.157 In 2003, the FDA released
151

The United States Food and Drug Administration, FDA News, FDA Takes Action
Against Foreign Websites Selling Counterfeit Contraceptive Patches, http://www.fda.gov/
newsevents/newsroom/pressannouncements/2004/ucm108246.htm (last visited Apr. 15,
2010).. “[T] he counterfeits were sent in simple plastic zip-lock bags without identifying
materials, lot numbers, expiration dating or any other labeling information needed to safely
and effectively use this prescription product.” Id.
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Id.
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Id. “FDA’s Office of Criminal Investigation is continuing to work with the Department
of Homeland Security’s Bureau of Immigration and Custom Enforcement (ICE) Cyber Crimes
Center to combat pharmaceutical counterfeiting and other illegal internet drug sales and take
effective action against those responsible.” Id.
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United States Food and Drug Administration, Cyber Letters 2008, http://www.fda.gov/
Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/CyberLette
rs/default.htm (last visited Oct. 30, 2009); One such cyber letter was sent to www.curacare.com, a website that purported to sell cancer treating creams and drugs. On its website,
Cura-Care.com described the effects of one its products with the following description:
“cancer on the surface of the skin tissue is treated and the deep penetrating delivery cream
then allows the active constituents to penetrate the skin and attack the whole cancer hidden
beneath the skin tissue.” Available at http://www.fda.gov/ICECI/ EnforcementActions/
WarningLetters/2008/ucm1048289.htm (last visited Oct. 30, 2009).
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FDA Talk Paper, FDA Launches “Cyber” Letters Against Potentially Illegal, Foreign
Based Online Drug Sites, http://web.archive.org/web/20080229052621/http://www.fda.gov/
bbs/topics/ANSWERS/ANS01001.html (last visited Apr. 12, 2010). At the time of the press
release, the FDA had only received one response from the cyber letter program indicating
compliance to cease illegal activities.
156

Drugs imported from Mexican pharmacies contained no active ingredients, FDA Talk
Paper, FDA Warns Consumers About Counterfeit Drugs Purchased in Mexico,
http://web.archive.org/web/20080223122244/http://www.fda.gov/bbs/topics/ANSWERS/2004
/ANS01303.html (last visited Apr. 12, 2010).
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a statement proclaiming “[i]n the U.S., generic drugs, which comprise roughly half
of all prescriptions, are cheaper than both Canadian branded drugs and Canadian
generic drugs.”158 In an examination of over 2000 drug packages at the United States
border, “47 percent of the sampled products can be bought for $4 at several national
chain pharmacies, a price often lower than the shipping costs for the same drugs
purchased online.”159
Existing regulations in the Controlled Substance Act already prohibit importing
controlled substances.160 Because drugs are still commonly imported anyway, some
scholars have made some unconventional suggestions ranging from simply lowering
the cost of prescription costs in the United States161 to forming an international
coalition of online pharmacies.162 While there is debate as to the foreign pharmacy
solution, federal legislators must not continue to ignore the problem.
D. Lifestyle Drugs
Lifestyle drugs are among the most popular items on online pharmacies.
Examples of lifestyle drugs include weight loss and sexual enhancement drugs,
which are not regulated by the Controlled Substances Act.163 While drugs of this
157

Food and Drug Administration, U.S./Canadian Price Comparisons October 2004,
http://web.archive.org/web/20080504232457/http://www.fda.gov/oc/opacom/hottopics/import
drugs/canadarx.html (last visited Apr. 12, 2010). The chart compiled by the FDA indicates
that for many consumers, drugs purchased domestically are far less expensive. The prices for
the Canadian drugs do not include a shipping charge, which is usually between $15.00 $30.00. Id.
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Food and Drug Administration, FDA White Paper, Generic Drug Prices in the U.S. Are
Lower Than Drug Prices in Canada, http://web.archive.org/web/20080223160716/http:/
/www.fda.gov/oc/whitepapers/drugprices.html (last visited Apr. 12, 2010). “In the U.S.,
generic drugs, which comprise roughly half of all prescriptions, are cheaper than both
Canadian branded drugs and Canadian generic drugs.” Id.
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Food and Drug Administration, FDA News, FDA Says Consumers Continue to Buy
Risky Drugs Online, http://web.archive.org/web/20080223200918/http://www.fda.gov/bbs/
topics/NEWS/2007/NEW01735.html (last visited Apr. 12, 2010). The FDA conducted a study
of drugs mailed to consumers from outside the United States. Most of the drugs purchased by
consumers were domestically available and several had inexpensive generic versions. The
FDA’s deputy commissioner for policy suggests that “‘many people are buying drugs online
not to save money but to bypass the need for a prescription from their doctor since these Web
sites typically do not require the purchaser to have a prescription’”. Id.
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21 U.S.C. § 952 (2006). “It shall be unlawful to import . . . into the United States from
any place outside thereof, any controlled substance in schedule I or II. . . [or] [n]onnarcotic
controlled substances in schedule III, IV, or V.” Id.
161

Ayers, supra note 5.
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Yoo, supra note 5.
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Dispensing and Purchasing Controlled Substances over the Internet, supra note 26; See
Drug Enforcement Administration, Office of Division Control, Questions and Answers:
Dispensing and Purchasing Controlled Substances Over the Internet, supra note 58. “Some
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control medications, and tranquilizers. Many of these so-called life style drugs are not
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type do not typically present a danger of addiction, they may still pose a danger to
individuals with medical complications.164 Lifestyle drugs, especially weight loss
and sexual enhancement drugs, are potentially dangerous to consumers with health
problems.
In Kansas ex rel. Stovall v. ConfiMed.com, L.L.C., an attorney general was able
to enjoin an out of state vendor from selling and dispensing medication to Kansas
residents after a sixteen year old obtained Viagra through an online questionnaire.
Ordinarily, teens would be unable to obtain Viagra without first consulting with a
physician. With the help of the internet, the teen was able to easily purchase the
Viagra. The Attorney General was hampered in his attempts to punish the vendor. In
the absence of legislation targeted at online pharmacies dispensing lifestyle drugs,
the Attorney General was forced to pursue a prosecution for unconscionable acts
under the Kansas Consumer Protection Act. The attempt failed, and the vendor was
spared of any meaningful consequences.165
Weight loss pills and sexual enhancement and erectile dysfunction pills are
targeted toward online consumers, often for privacy reasons. Consumers purchasing
weight loss or erectile dysfunction tablets may not want to be seen buying said
products at the local pharmacy, so they turn to the all too anonymous realm of online
pharmacies. The problem, however, is that because lifestyle drugs (also sometimes
called “dietary supplements”) are not subject to prescription or controlled substance
requirements, there is often little regulation to protect the consumer.166
Men, the FDA warns, should take care when ordering so called “dietary
supplements” because they often “contain prescription drugs or other undisclosed
ingredients that can be harmful.”167 The FDA found that more than one third of the
dietary supplements that claimed to increase sexual enhancement contained
prescription drug ingredients.168 Undisclosed prescription drug ingredients can be
164

Lifestyle Drug Binge, Businessweek.com, http://www.businessweek.com/magazine/
content/07_27/b4041048.htm (last visited Mar. 24, 2009). “On June 13 a panel of FDA
advisers voted unanimously not to recommend a weight-loss treatment called Acomplia . . .
.Though it is already approved in 37 countries, the FDA and its advisers are concerned about
reports linking it to depression and even suicidal tendencies.” Id.
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ConfiMed.com, L.L.C., 38 P.3d at 707 (failure to perform physical examination or
provide actual physical supervision and Viagra sale to a minor was not unconscionable).
“[F]inding . . . that there was no actual harm, nothing was misrepresented, and the product
furnished was authentic conclusively shows that potential unconscionable acts outside the
enumerated examples of [Kansas Consumer Protection Act] were considered.” Id.
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See generally Paula Kurtzweil, An FDA Guide to Dietary Supplements, http://www.
fda.gov/FDAC/features/1998/598_guid.html (last visited Mar. 24, 2009).
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United States Food and Drug Administration, Buying Fake ED Products Online,
http://web.archive.org/web/20080221175443/http://www.fda.gov/consumer/updates/erectiledy
sfunction010408.html (last visited Feb. 12, 2009). “Men looking online for ‘dietary
supplements’ to treat erectile dysfunction (ED) or enhance their sexual performance should
beware: these products may contain prescription drugs or other undisclosed ingredients that
can be harmful.” Id.
168
Id. “Six of the 17 products we bought contained sildenafil (the active ingredient in
Viagra) or a substance similar to either sildenafil or vardenafil,’ says [Linda Silvers, leader of
FDA's Internet and Health Fraud Team]. Vardenafil is the active ingredient in Levitra, another
FDA-approved prescription drug that treats ED.” Id.
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potentially dangerous for consumers with “diabetes, high blood pressure, high
cholesterol, or heart disease.”169 On a similar note, the FDA released a list of
recalled dietary supplements that were advertised as weight loss pills.170 The weight
loss pills, most of which were obtained from online pharmacies, were recalled
because “they contain undeclared ingredients and, in some cases, contain
prescription drugs in amounts that greatly exceed their maximum recommended
dosages.”171 As it stands, the Ryan Haight Act will not do anything to regulate the
trade of lifestyle drugs or dietary supplements via online pharmacies. Congress must
address dangerous distribution of medication by irresponsible online pharmacies.
E. Drug Manufacturers
As the ultimate source of prescription medication, legislators must not ignore the
role that drug manufacturers play in allowing drugs to be readily distributed by
dangerous online pharmacies. Kelly v. Qualitest Pharmaceuticals, Inc. involved a
surviving family member and a drug manufacturer in a wrongful death suit. The
Kelly court provided a detailed description of the dangerous relationship between
drug manufacturers and online pharmacies.
Online pharmacies . . . are able to purchase virtually unlimited supplies of
controlled substances from manufacturers… which employ specific
distributors to market the manufacturer’s products. The distributors, with
the authority of the manufacturer, allow the drugs which are
governmentally regulated because of the dangers the drugs present if
improperly used, to enter the stream of commerce unrestrained.”172
Later in the opinion, the court declined to extend tort liability to the manufacturer
because “[i]t does not appear that Qualitest was a party to the on-line transaction,

169
United States Food and Drug Administration, Buying Fake ED Products Online,
Http://www.fda.gov/consumer/updates/erectiledysfunction010408.html (last visited Feb. 12,
2009). The FDA provides a list of erectile dysfunction products sold online to avoid. The list
is available at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048386.htm Id.
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Food and Drug Administration, FDA News, FDA Expands Warning to Consumers
About Tainted Weight Loss Pills, http://www.fda.gov/NewsEvents/Newsroom/Press
Announcements/2008/ucm116998.htm (last visited Feb. 12, 2009). “December 22, 2008, FDA
warned consumers not to purchase or consume 28 different products marketed for weight loss.
Since that time, FDA analysis has identified 41 more tainted weight loss products that may put
consumers’ health at risk.” Id.
171
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phenolphthalein (. . . used in chemical experiments and a suspected cancer causing agent) and
bumetanide (a diuretic).” Id.
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Kelly v. Qualitest Pharms., Inc., 2006 U.S. Dist. LEXIS 65814 (E.D. Cal. Aug. 28,
2006), at *4 (Plaintiff’s allegation that Defendant was “negligent in the sales, distribution, and
control of the dangerous and controlled substance . . . [and] approved the sale . . . to . . .
‘rogue’ pharmacies without reasonable investigation into the business practices of the
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rather, the only apparent role that Qualitest played was manufacturing [the drug].”173
If online pharmacies are to be safely regulated, their source for these medications
must be controlled. In order to create truly effective online pharmacies, drug
manufacturers must be required to conduct “a reasonable investigation into the
practices, licensure, and insurance status of the pharmacies”174 before shipping or
selling medication to online pharmacies.
I recommend that future federal online pharmacy regulation should be modeled
after the California statute cited in Kelly.175 The statute reads, in part, “No
wholesaler or manufacturer … shall furnish controlled substances for other than
legitimate purposes.”176 California defines mens rea177 as “knowing, or having
conscious disregard for the fact, that the controlled substances are for other than a
legitimate medical purpose . . . .”178 If adopted on a federal level, this statute would
impose a duty on drug manufacturers to sell controlled substances to legitimate
online pharmacies. If taken further, future legislation could limit the sale of
controlled substances solely to DEA endorsed pharmacies.
V. WHY THE RYAN HAIGHT WILL BE SUCCESSFUL
The Ryan Haight Act will likely be successful in regulating online pharmacies
because other industries have succeeded in the transition from brick and mortar to an
online presence. The Ryan Haight Act legislation represents themes of consumer
rights and protection, a transition to federal regulation, a transition to internet-based
services and the growing recognition of the need for regulation to keep pace with
advances in technology. These themes are consistent with successful legislation
exemplified in other sectors.
A. Online Banking
The transition of the banking industry away from brick and mortar to online
banking179 draws many similarities to the transition that pharmacies are undergoing.
The regulation of online banking, like that of online pharmacies, strives to put brick
and mortar institutions on the same ground as online entities. One method of
173

Id. at *31.
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Id. at *28.
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Cal. Health & Saf. Code § 11153.5 (1988).
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Id.

“Factors to be considered in determining . . . [mens rea] shall include, but not be limited
to, whether the use of controlled substances was for purposes of increasing athletic ability or
performance, the amount of controlled substances furnished, the previous ordering pattern of
the customer (including size and frequency of orders), the type and size of the customer, and
where and to whom the customer distributes the product.” Id.
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Black's Law Dictionary (8th ed. 2004), mens rea. Black’s Law Dictionary defines mens
rea as “The state of mind that the prosecution, to secure a conviction, must prove that a
defendant had when committing a crime.” Id.
178
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Online banking as extension of brick and mortar banks are often called “bricks and
clicks” banking.
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achieving this has been to amend a successful regulatory framework that is already in
place to reflect technological advances. Just as the Ryan Haight Act amended the
Controlled Substances Act, the Federal Reserve’s lettered regulations have been
amended to reflect changes in technology. For example, “Regulation E” was
implemented to regulate electronic fund transfers.180
To the consumer, online banking offers many of the same advantages and risks
associated with online pharmacies. The advantages in online banking revolve
around convenience, efficiency, speedy transactions, and the ability to bank from
anywhere with internet access. The risks, although not life threatening, are still very
serious. The risks of online banking revolve around trust and the potential of fraud.
To address the risks, a great deal of banking regulation has been geared toward
consumer protection and disclosure requirements. The Federal Deposit Insurance
Corporation (FDIC) published a brochure to educate consumers on how to avoid the
perils of online banking181 that seems to mirror many of the consumer education
publications put out by the FDA182 and DEA.183
The similarity between the efforts of online banking regulations and online
pharmacy regulations are striking. In its brochure, the FDIC warns consumers to
“[c]onfirm that an online bank is legitimate and that your deposits are insured, [k]eep
your personal information private and secure, [u]nderstand your rights as a
consumer, and [l]earn where to go for more assistance from banking regulators.”184
With the exception of privacy, the above requirements look as if they were drawn
from the Ryan Haight Act. In both banking and pharmacies, online trust is
established through the use of an endorsing agency, be it the FDIC or DEA.
Next, banks are required to make certain disclosures, exemplified by the Truth in
Lending act. The Truth in Lending Act requires banks to disclose lending terms and
arrangements – which are essential to informing and protecting the consumer
concerning banking practices.185 The Ryan Haight Act also requires disclosure of
information essential to the safe and successful operation of a pharmacy dispensing
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12 C. F. R. § 205.1, et seq. (1996). The amendment to Regulation E “establishes the
basic rights, liabilities, and responsibilities of consumers who use electronic fund transfer
services and of financial institutions that offer these services. The primary objective of the act
and this part is the protection of individual consumers engaging in electronic fund transfers.”
Id.
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potentially deadly drugs, such as the name of the pharmacist and how to contact the
pharmacy.
Banking’s track record of successful regulation, smooth transition onto the
internet, and emphasis on consumer protection, demonstrate that federal regulation
may be appropriate for online activities that were once only done in brick and mortar
facilities, such as purchasing and selling medication. Additionally, many of the
consumer regulations in the banking industry, such as disclosure and the use of an
endorsing agency, are parallel to the consumer regulations in the Ryan Haight Act.
The continued growth in online banking demonstrates that consumers are willing to
make the transition to online entities when proper consumer protection exists.
B. Increasing Role of the Internet
For both legislators and the public at large, it is becoming harder and harder to
ignore the influence of the internet. The internet is fast becoming ubiquitous as its
presence seems to increase daily. According to the Pew Internet & American Life
Project, an initiative of the Pew Research Center, more than half of American
households have high-speed internet access.186 The Pew Internet & American Life
Project also reports that the fastest growing group of internet users is over 70 years
old.187 It is not unreasonable to assume that an increasing population of seniors on
the internet will contribute to the growth of online pharmacies. As the percentage of
the population that may be exposed to potentially dangerous online pharmacies
grows, the demand for effective regulation will become harder to ignore.
VI. CONCLUSION
In sum, The Ryan Haight Online Consumer Protection Act of 2008 is a much
needed first step toward meaningful regulation of online pharmacies. The DEA
registration, efforts to increase online pharmacy transparency, public notice and
balance, serve as strengths of the Act. However, several of the Act’s shortcomings
must be addressed in future legislation. Improvements for future legislation must
address aspects of online pharmacies unique to the internet, such as web
intermediaries, web hosts, and patient privacy concerns. The regulation must also be
expanded to include readily available and often dangerous lifestyle drugs. Larger
problems, such as the liability of drug manufacturers and foreign pharmacies must
also be addressed in any future legislation.
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187
SeniorJournal.com - Senior Citizens Information and News, Senior Citizens and
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